Principal Financial Group Inc Organogenesis Holdings Inc. Transaction History

Principal Financial Group Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$2.28 - $3.03 $6,787 - $9,020	2,977 Added 8.48%	38,065 $106,000
Q1 2024 Apr 29, 2024	BUY	$2.61 - $4.49 $91,579 - $157,545	35,088 New	35,088 $99,000
Q3 2023 Nov 02, 2023	BUY	$2.34 - $4.43 $23,636 - $44,747	10,101 New	10,101 $32,000
Q1 2023 May 09, 2023	SELL	$1.89 - $2.93 $821,509 - $1.27 Million	-434,661 Reduced 93.39%	30,746 $65,000
Q4 2022 Feb 09, 2023	BUY	$2.48 - $3.43 $26,471 - $36,611	10,674 Added 2.35%	465,407 $1.25 Million
Q3 2022 Nov 09, 2022	BUY	$3.14 - $6.43 $33,657 - $68,923	10,719 Added 2.41%	454,733 $1.47 Million
Q2 2022 Aug 10, 2022	SELL	$4.74 - $8.15 $180,096 - $309,659	-37,995 Reduced 7.88%	444,014 $2.17 Million
Q1 2022 May 09, 2022	SELL	$6.47 - $9.57 $116,899 - $172,910	-18,068 Reduced 3.61%	482,009 $3.67 Million
Q4 2021 Feb 09, 2022	BUY	$9.02 - $13.5 $23,722 - $35,505	2,630 Added 0.53%	500,077 $4.62 Million
Q3 2021 Nov 09, 2021	BUY	$13.71 - $17.18 $1.1 Million - $1.37 Million	79,930 Added 19.14%	497,447 $7.08 Million
Q2 2021 Aug 10, 2021	BUY	$14.92 - $23.23 $6.23 Million - $9.7 Million	417,517 New	417,517 $6.94 Million

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $505M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.